| Patients (Studies) Included | Milrinone: Events (%) | Control: Events (%) | RR | 95% CI | p for Effect | I2 (p for heterogeneity) |
---|---|---|---|---|---|---|---|
Myocardical Infarction | 440 (30) | 5 (2.28%) | 25 (11.31%) | 0.23 | 0.10–0.54 | 0.0008 | 9% (0.35) |
Myocardial Ischemia | 212 (53) | 12 (11.32) | 41 (36.68) | 0.29 | 0.16–0.52 | <  0.0001 | 0% (0.55) |
Arrhythmias | 470 (47) | 16 (6.84) | 31 (13.14) | 0.53 | 0.31–0.91 | 0.02 | 0% (0.55) |
Stroke | 172 (2) | 2 (2.33) | 0 (0) | 3.00 | 0.32–27.88 | 0.33 | 0% (1.00) |
Renal Failure | 302 (17) | 9 (5.96) | 8 (5.30) | 1.25 | 0.45–2.81 | 0.80 | 0% (0.64) |